Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antibody immunization

The field of DNA vaccination started when eukaryotic expression vectors were injected into the muscle of laboratory animals [2]. The authors observed protein expression for more than 2 months after injection and noted that no special delivery system was required to obtain this expression. Subsequently, it was demonstrated that antibodies can be induced simply by injecting plasmid DNA into the muscle of mice [3]. Subsequent studies found that the injection of expression plasmids also leads to the induction of a cytotoxic T-cell response. After injection, the DNA enters cells of the vaccinated host and the encoded gene becomes expressed. This eventually leads to the induction of a cellular cytotoxic T-cell, T-helper, and/or humoral (antibody) immune response. [Pg.433]

From a manufacturing standpoint, preparation of the double-antibody immune complex can be very labor intensive. For optimal manufacturability and analytical performance of this system, it is important to have a secondary antibody with a moderate to high affinity so that a mixture of immune complexes of appropriate molecular weights is formed. The molecular size and shape of complexes formed depends on a number of parameters, such as temperature, buffer characteristics, ionic strength and the presence of other solution components such as detergents. These conditions must be carefully controlled or else species of very high molecular weight could be formed due to temperature or buffer interactions. Lot-to-lot variability in the primary and secondary antibody raw materials can also affect the solid phase performance if not properly controlled. [Pg.465]

Figure 19.1 Dose-dependent response curve for thyroxine (T4) assay using E5-Ab and double-antibody immune complex. Solutions (20 juL) of the reference samples containing 0.0 to 25.0 /ig/dL T4 were mixed with 180 fiL of the releasing solution. Fractions (132 juL) of this mixture were combined with 38 //Lof an E5-Ab solution. After standard incubation, 76 A. of this mixture was spotted on a blank Stratus tab. Incubation times and reagent volumes used for the rest of the reagents, such as the conjugate and the substrate wash, were identical to those defined for an existing T4 assay on Stratus ... Figure 19.1 Dose-dependent response curve for thyroxine (T4) assay using E5-Ab and double-antibody immune complex. Solutions (20 juL) of the reference samples containing 0.0 to 25.0 /ig/dL T4 were mixed with 180 fiL of the releasing solution. Fractions (132 juL) of this mixture were combined with 38 //Lof an E5-Ab solution. After standard incubation, 76 A. of this mixture was spotted on a blank Stratus tab. Incubation times and reagent volumes used for the rest of the reagents, such as the conjugate and the substrate wash, were identical to those defined for an existing T4 assay on Stratus ...
In nearly all cases studied, the amount of primary antibody required in the E5-Ab complex to perform an assay has been found to be substantially less than that required for the double antibody immune complex format. This was found to be the case (Table 19.1) when the E5-Ab complex was either directly immobilized on the solid phase, to imitate the double-antibody immune complex format, or utilized in a solution phase format [12],... [Pg.474]

Table 19.2 Sensitivity determination with analyte-specific primary antibody in the form of a dendrimer complex or a double-antibody immune complex... Table 19.2 Sensitivity determination with analyte-specific primary antibody in the form of a dendrimer complex or a double-antibody immune complex...
The separated proteins were transferred to a polyvinylidene difluoride membrane, and nonspecific IgC binding sites were blocked by incubation with 5% nonfat dry milk for 1 h at room temperature. The membranes were then incubated overnight at 4°C with primary antibodies. Immune complexes were detected by enhanced chemiluminescence (Amersham Biosciences). [Pg.124]

The potential for immune responses against biologies (hypersensitivity, anti-drug antibodies, immune complexes, etc.) is something that most stent (alone or as drug-coated stents) manufacturers have not had to consider in prior development programs. [Pg.795]

Class II molecules interact exclusively with CD4-I- ( helper ) T-cells (THs). The THs then help to trigger an appropriate immune response, which may include localised inflammation and swelling due to recruitment of phagocytes, or may lead to a full-force antibody immune response due to activation of B-cells. [Pg.238]

In this case, which was marked by three autoimmune complications (insulin-dependent diabetes mellitus, myositis, and myasthenia gravis) in a single patient, a retrospective analysis of the patient s serum before aldesleukin therapy showed the presence of antibodies against glutamic acid decarboxylase, insulin, islet cell antigen, and striated muscle, but was negative for acetylcholine receptor antibodies. Immune stimulation by aldesleukin was... [Pg.65]

Hemolysis has also been reported with metamizole (11). It is possibly due to cell membrane absorption of drug-antibody immune complexes. [Pg.2269]

Pardridge, W. M. Bickel, U. Buciak, J. Yang, J. Diagne, A. Aepinus, C. Cationization of a monoclonal antibody to the human immunodeficiency virus REV protein enhances cellular uptake but does not impair antigen binding of the antibody. Immun. Lett. 1994, 42, 191-195. [Pg.212]

For the production of monoclonal antibodies, immunization may be achieved either in vivo (most common) or in vitro. Immunization in culture and subsequent production of monoclonal antibodies may carry several important advantages (reviewed by Reading, 1982) ... [Pg.64]

Veronese SM, Barbareschi M, Morelli L, et al. Predictive value of ER1D5 antibody immune staining in breast cancer A paraffin-based retrospective study of 257 cases. Appl Immunohisto-chetn. 1993 3 85-90. [Pg.818]

Shankar, G., Pendley, C., and Stein, K.E. (2007) A risk based hioanalytical strategy for the assessment of antibody immune responses against biological drugs. Nature Biotechnology, 25, 555 561. [Pg.234]


See other pages where Antibody immunization is mentioned: [Pg.578]    [Pg.164]    [Pg.368]    [Pg.465]    [Pg.466]    [Pg.469]    [Pg.474]    [Pg.657]    [Pg.94]    [Pg.244]    [Pg.244]    [Pg.208]    [Pg.646]    [Pg.954]    [Pg.1207]    [Pg.142]    [Pg.49]    [Pg.58]    [Pg.323]    [Pg.242]    [Pg.302]    [Pg.783]    [Pg.207]    [Pg.60]    [Pg.598]    [Pg.111]    [Pg.300]    [Pg.162]    [Pg.344]    [Pg.354]    [Pg.428]    [Pg.428]    [Pg.901]    [Pg.578]    [Pg.250]   
See also in sourсe #XX -- [ Pg.51 , Pg.52 , Pg.53 , Pg.54 , Pg.55 ]




SEARCH



Anti-carbohydrate antibodies immunization

Antibodies Immunity

Antibodies Immunity

Antibodies and the Immune Response

Antibodies humoral immune response

Antibodies immune sera

Antibodies passive acquired immunity

Antibodies reactive immunization

Antibodies role in immunization

Antibody immune effectors

Antibody immunization schedule

Antibody post-immunization

Antibody synthesis Immune system

Antibody-mediated immunity

Anticarbohydrate antibodies immunization

Humoral Immunity (Antibody Responses)

Immune complex disease monoclonal antibodies

Immune response antibodies

Immune response antigen-antibody binding

Immune system Antibodies, Antibody

Immune system antibodies

Immunization and antibody production

Immunization antibody produced

Immunization antibody response

Immunization specific antibody separation

Immunologic agents antibody-mediated immunity

Monoclonal antibodies immune responses against

Monoclonal antibodies immunization

Production of monoclonal antibodies after in vitro immunization

Production of monoclonal antibodies after in vivo immunization

© 2024 chempedia.info